International Journal of Hematology · 2008 · 56 citations · 39 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyMolecular PharmacologyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyPersonalized Cancer TherapyMyeloma Cell LinesMyeloma PathogenesisTargeted Combination ChemotherapyTargeted Therapy Pharmacology
39
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations
β‐catenin is a target for the ubiquitin–proteasome pathway
Hermann Aberle, Andreas Bauer, Jörg Stappert et al. · The EMBO Journal · 1997 · 2.5K citations